Temporal declines in bone mineral density and trabecular bone score during androgen deprivation therapy.
Androgen deprivation therapy
Bone mineral density
Prostate cancer
Trabecular bone score
Journal
Journal of bone and mineral metabolism
ISSN: 1435-5604
Titre abrégé: J Bone Miner Metab
Pays: Japan
ID NLM: 9436705
Informations de publication
Date de publication:
12 Sep 2024
12 Sep 2024
Historique:
received:
25
03
2024
accepted:
26
06
2024
medline:
13
9
2024
pubmed:
13
9
2024
entrez:
12
9
2024
Statut:
aheadofprint
Résumé
The trabecular bone score (TBS) has emerged as a convenient measure for assessing the microstructure of trabecular bone in the second through fourth lumbar vertebrae (L2-4) and can be conducted concurrently with bone mineral density (BMD) assessment. This study was performed to evaluate changes in BMD and the TBS during ADT for prostate cancer. Consecutive patients who had prostate cancer without bone metastases at Kobe University Hospital were studied from March 2020 to December 2021. BMD and TBS were measured every 6 months from the start of treatment using Hologic Horizon devices (Hologic, Inc., Marlborough, MA, USA). Thirty-four patients were followed for 2 years. Significant declines in BMD (-3.8% for femoral neck, -4.2% for total hip, and -6.1% for lumbar spine) and TBS (-16.6%) were noted after 2 years of ADT. Correlation analyses revealed a weak correlation between lumbar spine BMD and TBS at ADT initiation, but this correlation strengthened after 2 years. The multiple regression analysis results suggested that the rate of BMD loss may be slower in patients with a preserved pretreatment TBS. In patients without bone metastases undergoing ADT for prostate cancer, notable decreases were found in both BMD and TBS over a 2-year treatment period. Factors influencing the TBS decline remain unclear; however, patients with a lower pretreatment TBS exhibited a more rapid decline in BMD.
Identifiants
pubmed: 39266779
doi: 10.1007/s00774-024-01537-z
pii: 10.1007/s00774-024-01537-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Japanese Society Bone and Mineral Research.
Références
Desai K, McManus JM, Sharifi N (2021) Hormonal therapy for prostate cancer. Endocr Rev 42:354–373
doi: 10.1210/endrev/bnab002
pubmed: 33480983
pmcid: 8152444
Gómez Rivas J, Fernandez L, Abad-Lopez P, Moreno-Sierra J (2023) Androgen deprivation therapy in localized prostate cancer. Current status and future trends. ActasUrol Esp 47:398–407
Nguyen PL, Alibhai SMH, Smith MR et al (2015) Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 67:825–836
doi: 10.1016/j.eururo.2014.07.010
pubmed: 25097095
Greenspan SL, Coates P, Sereika SM, Nelson JB, Trump DL, Resnick NM (2005) Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 90:6410–6417
doi: 10.1210/jc.2005-0183
pubmed: 16189261
Wang A, Obertová Z, Brown C, Lawrenson R et al (2015) Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand. BMC Cancer 15:837
doi: 10.1186/s12885-015-1843-3
pubmed: 26525985
pmcid: 4631090
Fukumoto S, Soen S, Matsumoto T, Subcommittee for CTIBL in the JSBMR et al (2020) Management manual for cancer treatment-induced bone loss (CTIBL): position statement of the JSBMR. J Bone Miner Metab 38:141–144
doi: 10.1007/s00774-020-01087-0
pubmed: 32020289
Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J, ESMO Guidelines Working Group (2014) Bone health in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol 25:124–137
doi: 10.1093/annonc/mdu103
Licata A (2009) Bone density vs bone quality: what’s a clinician to do? Cleve Clin J Med 76:331–336
doi: 10.3949/ccjm.76a.08041
pubmed: 19487553
Compston J (2006) Bone quality: what is it and how is it measured? Arq Bras Endocrinol Metabol 50:579–585
doi: 10.1590/S0004-27302006000400003
pubmed: 17117283
Rajan R, Cherian KE, Kapoor N, Paul TV (2020) Trabecular bone score-an emerging tool in the management of osteoporosis. Ind J Endocrinol Metab 24:237–243
doi: 10.4103/ijem.IJEM_147_20
Pothuaud L, Barthe N, Krieg M-A, Mehsen N, Carceller P, Hans D (2009) Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study. J Clin Densitom 12:170–176
doi: 10.1016/j.jocd.2008.11.006
pubmed: 19181553
Soen S, Fukunaga M, Sugimoto T et al (2013) Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab 31:247–257
doi: 10.1007/s00774-013-0447-8
pubmed: 23553500
Kanda Y (2013) Investigation of the freely-available easy-to-use software “EZR” (Easy R) for medical statistics. Bone Marrow Transplant 48:452–458
doi: 10.1038/bmt.2012.244
pubmed: 23208313
Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 42:775–787
doi: 10.1016/j.bone.2007.11.018
pubmed: 18234577
Pothuaud L, Barthe N, Krieg M-A, Mehsen N, Carceller P, Hans D (2009) Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: apreliminary spine BMD-matched, case-control study. J Clin Densitom 12:170–176
doi: 10.1016/j.jocd.2008.11.006
pubmed: 19181553
Choi YJ, Chung Y-S, Suh C-H, Jung J-Y, Kim H-A (2017) Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore) 96:e8661
doi: 10.1097/MD.0000000000008661
pubmed: 29137106
Kim HA, Lee HY, Jung JY, Suh CH, Chung YS, Choi YJ (2020) Trabecular bone score is a useful parameter for the prediction of vertebral fractures in patients with polymyalgia Rheumatica. J Clin Densitom 23:373–380
doi: 10.1016/j.jocd.2019.05.006
pubmed: 31174962
Leslie WD, Aubry-Rozier B, Lix LM, Morin SN, Majumdar SR, Hans D (2014) Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba bone density program. Bone 67:10–14
doi: 10.1016/j.bone.2014.06.034
pubmed: 24998455
Martineau P, Leslie WD, Kanis JA et al (2018) In which patients does lumbar spine trabecular bone score (TBS) have the largest effect? Bone 113:161–168
doi: 10.1016/j.bone.2018.05.026
pubmed: 29802962
pmcid: 6013036
Iki M, Tamaki J, Yoneshima H et al (2014) Trabecular bone score (TBS) predicts vertebral fractures in Japanese women over 10 years independently of bone density and prevalent vertebral deformity: the Japanese population-based osteoporosis (JPOS) cohort study. J Bone Miner Res 29:399–407
doi: 10.1002/jbmr.2048
pubmed: 23873699
Tang H, Di W, Cai J et al (2022) Age-related changes in trabecular bone score and bone mineral density in chinese men: a cross-sectional and longitudinal study. Clin Interv Aging 17:429–437
doi: 10.2147/CIA.S358951
pubmed: 35418748
pmcid: 8999684
Schousboe JT, Vo TN, Schwartz AV et al (2018) Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study. Osteoporos Int 29:49–59
doi: 10.1007/s00198-017-4273-z
pubmed: 29090329
Krieg MA, Aubry-Rozier B, Hans D, Leslie WD (2013) Manitoba Bone Density P. Effects of antiresorptive agents on trabecular bone score (TBS) in older women. Osteoporos Int 24:1073–1078
doi: 10.1007/s00198-012-2155-y
pubmed: 23052939
Popp AW, Guler S, Lippuner K et al (2013) Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study. J Bone Miner Res 28:449–454
doi: 10.1002/jbmr.1775
pubmed: 23018784
Berruti A, Dogliotti L, Tarabuzzi R et al (2002) Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. J Urol 167:2361–2367
doi: 10.1016/S0022-5347(05)64985-3
pubmed: 11992038
Maillefert JF, Sibilia J, Michel F, Saussine C, Javier RM, Tavernier C (1999) Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma. J Urol 161:1219–1222
doi: 10.1016/S0022-5347(01)61639-2
pubmed: 10081873
Finkelstein JS, Brockwell SE, Neer RM et al (2008) Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab 93:861–868
doi: 10.1210/jc.2007-1876
pubmed: 18160467
Shigehara K, Izumi K, Kadono Y, Mizokami A (2021) Testosterone and bone health in men: a narrative review. J Clin Med 10:530
doi: 10.3390/jcm10030530
pubmed: 33540526
pmcid: 7867125
Wiren KM, Chapman Evans A, Zhang XW (2002) Osteoblast differentiation influences androgen and estrogen receptor-alpha and -beta expression. J Endocrinol 175:683–694
doi: 10.1677/joe.0.1750683
pubmed: 12475379
Leifke E, Körner HC, Link TM, Behre HM, Peters PE, Nieschlag E (1998) Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol 138:51–58
doi: 10.1530/eje.0.1380051
pubmed: 9461316
Cauley JA, Ellenberg SS, Schwartz AV, Ensrud KE, Keaveny TM, Snyder PJ (2021) Effect of testosterone treatment on the trabecular bone score in older men with low serum testosterone. Osteoporos Int 32:2371–2375
doi: 10.1007/s00198-021-06022-1
pubmed: 34080044
pmcid: 8563386
Bazzocchi A, Ponti F, Guglielmi G et al (2015) Trabecular bone score in healthy ageing. Br J Radiol 88:20140865
doi: 10.1259/bjr.20140865
pubmed: 26148778
pmcid: 4651387
Rajaei A, Amiri A, Farsad F, Dehghan P (2019) The correlation between trabecular bone score and lumbar spine bone mineral density in patients with normal and high body mass index. Iran J Med Sci 44:374–381
pubmed: 31582861
Schousboe JT, Vo TN, Ensrud KE et al (2018) Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study. Osteoporos Int 29:49–59
doi: 10.1007/s00198-017-4273-z
pubmed: 29090329
Padlina I, Gonzalez-Rodriguez E, Lamy O et al (2017) The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort. Osteoporos Int 28:909–915
doi: 10.1007/s00198-016-3829-7
pubmed: 27900426
Franco F, Borau Zamora C, Martín Campana D, Berli ME (2023) Computational analysis of the influence of menopause and ageing on bone mineral density, exploring the impact of bone turnover and focal bone balance—a study on overload and underload scenarios. Life (Basel) 13:2155
pubmed: 38004295
Seeman E (1997) From density to structure: growing up and growing old on the surfaces of bone. J Bone Miner Res 12:509–521
doi: 10.1359/jbmr.1997.12.4.509
pubmed: 9101362
Miyazawa Y, Sekine Y, Suzuki K et al (2018) Effect of androgen-deprivation therapy on bone mineral density in Japanese patients with prostate cancer. In Vivo 32:409–412
pubmed: 29475929
pmcid: 5905214
van Londen GJ, Levy ME, Perera S, Nelson JB, Greenspan SL (2008) Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study. Crit Rev Oncol Hematol 68:172–177
doi: 10.1016/j.critrevonc.2008.06.006
pubmed: 18706829
pmcid: 2826163
Romagnoli E, Lubrano C, Lenzi A et al (2016) Assessment of trabecular bone score (TBS) in overweight/obese men: effect of metabolic and anthropometric factors. Endocrine 54:342–347
doi: 10.1007/s12020-016-0857-1
pubmed: 26815904